Henrik Sengelov

Has grant

professor

University of Copenhagen

Denmark

Research Interests

Explore related searches

Professors in Immunology

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Henrik Sengelov is a professor at the University of Copenhagen, Denmark. His research primarily focuses on hematopoietic cell transplantation, including clinical infections, posttransplant lymphoproliferative disease, and the impact of the gut microbiome on antibiotic resistance. He has authored several recent articles addressing critical issues in the field, highlighting the significance of factors such as pulmonary function and ocular graft-versus-host disease in patient outcomes.

Recent Grants

Grant: Close

Role of gamma/delta T cells in allogeneic stem cell transplantation

Open Date: 2015-10-01

Close Date: 2020-09-01

Articles (14)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Klaus Müller

Professor

Rigshospitalet

DENMARK

View details

Quentin RILLER

Imagine Institute for Genetic Diseases

FRANCE

View details

Annette Raskov Kodahl

Odense University Hospital

DENMARK

View details

Roger Paredes

Chief

Hospital Universitari Germans Trias i Pujol

SPAIN

View details

Jean-Luc Lenormand

Professor

Université Grenoble Alpes

FRANCE

View details

Cameron MacPherson

Head of Health Informatics

Rigshospitalet

DENMARK

View details

Tayfun Güngör

University of Zurich

SWITZERLAND

View details

Maria Ebbesen Sørum

Københavns Universitet

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Henrik Sengelov

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (14)

HLA-haploidentical stem cell transplantation for chronic granulomatous disease: an EBMT-IEWP retrospective study

The Diagnostic Value of Soluble Epstein-Barr Virus BZLF1 Protein in Posttransplant Lymphoproliferative Disease Among Solid Organ and Hematopoietic Cell Transplant Recipients

The Gut Microbiome and Its Resistome as Predictors of Clinical Infections and Phenotypic Antibiotic Resistance in Hematopoietic Stem Cell Transplant Recipients

Methotrexate Versus Mycophenolate Mofetil Prophylaxis in Allogeneic Hematopoietic Cell Transplantation for Chronic Myeloid Malignancies: A Retrospective Analysis on Behalf of the Chronic Malignancies Working Party of the EBMT

Pulmonary function is a strong predictor of 2‐year overall survival and non‐relapse mortality after allogenic hematopoietic cell transplantation

Thymic stromal lymphopoietin levels after allogeneic hematopoietic stem cell transplantation

Severity and 90-day survival of SARS-CoV-2 infection among patients with haematological disorders

Ocular graft-versus-host disease and dry eye disease after paediatric haematopoietic stem cell transplantation - incidence and risk factors

Chronic ocular graft-versus-host disease after allogeneic haematopoietic stem cell transplantation in Denmark – factors associated with risks and rates in adults according to conditioning regimen

SARS‐CoV‐2 infection among patients with haematological disorders: Severity and one‐month outcome in 66 Danish patients in a nationwide cohort study

Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation.

Vitamin E and acute graft‐versus‐host disease after myeloablative allogeneic hematopoietic cell transplantation

Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients

Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation

Collaborators (8)

Klaus Müller

Quentin RILLER

Annette Raskov Kodahl

Roger Paredes

Jean-Luc Lenormand

Cameron MacPherson

Tayfun Güngör

Maria Ebbesen Sørum

Make your next move.